Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Metavia Inc (MTVA)

Metavia Inc (MTVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Metavia Inc 545 Concord Avenue Suite 210 Cambridge MA 02138 USA

www.metaviatx.com Employees: 9 P: 857-702-9600

Sector:

Medical

Description:

MetaVia Inc. is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases. MetaVia Inc., formerly known as NeuroBo Pharmaceuticals Inc., is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 3,544
Enterprise Value, $K -12,476
Shares Outstanding, K 2,201
Float, K 2,184
% Float 99.20%
Short Interest, K 62
Short Float 2.84%
Days to Cover 1.00
Short Volume Ratio 0.24
% of Insider Shareholders 0.80%
% of Institutional Shareholders 1.37%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -27,590 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,380 K
EBIT, $ -17,250 K
EBITDA, $ -17,230 K

Growth:

1-Year Return -90.43%
3-Year Return -97.61%
5-Year Return -99.98%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 99.64%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.54 on 11/06/25
Next Earnings Date 03/19/26 [--]
Earnings Per Share ttm -8.36
EPS Growth vs. Prev Qtr 46.15%
EPS Growth vs. Prev Year 74.55%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-11 on 12/05/25

MTVA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -229.48%
Return-on-Assets % -105.28%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.56
Book Value/Share 2.88
Interest Coverage -30.99
60-Month Beta 0.27
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar